glutathione and triple negative breast cancer Epithelial, Mesenchymal, Hybrid triple-negative GPX4 in triple-negative breast cancer:
GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Full article: Glutathione and acid dual responsive nanomaterials loaded with methotrexate and magnolol for triple negative breast cancer treatment Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




